Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

NCT03817502 is registered in ClinicalTrials.gov with Gedeon Richter Plc. as lead sponsor.

NCT NCT03817502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Lead sponsor
Gedeon Richter Plc.
Phase
Phase 3
Overall status
Recruiting
Start date
June 6, 2019
Completion date
December 15, 2026
Enrollment
330 (estimated)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia